- Home
- PMCB vs MFI Comparison
PMCB vs MFI Comparison
Compare PMCB & MFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- MFI
- Stock Information
- Founded
- PMCB 1996
- MFI 2002
- Country
- PMCB United States
- MFI Hong Kong
- Employees
- PMCB N/A
- MFI N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- MFI
- Sector
- PMCB Health Care
- MFI
- Exchange
- PMCB Nasdaq
- MFI NYSE
- Market Cap
- PMCB 7.3M
- MFI 8.2M
- IPO Year
- PMCB N/A
- MFI 2024
- Fundamental
- Price
- PMCB $1.11
- MFI $4.93
- Analyst Decision
- PMCB
- MFI
- Analyst Count
- PMCB 0
- MFI 0
- Target Price
- PMCB N/A
- MFI N/A
- AVG Volume (30 Days)
- PMCB 12.0K
- MFI 1.3M
- Earning Date
- PMCB 08-12-2025
- MFI 04-23-2025
- Dividend Yield
- PMCB N/A
- MFI N/A
- EPS Growth
- PMCB N/A
- MFI N/A
- EPS
- PMCB 1.29
- MFI N/A
- Revenue
- PMCB N/A
- MFI $3,358,264.00
- Revenue This Year
- PMCB N/A
- MFI N/A
- Revenue Next Year
- PMCB N/A
- MFI N/A
- P/E Ratio
- PMCB $0.86
- MFI N/A
- Revenue Growth
- PMCB N/A
- MFI N/A
- 52 Week Low
- PMCB $1.00
- MFI $0.51
- 52 Week High
- PMCB $2.42
- MFI $6.95
- Technical
- Relative Strength Index (RSI)
- PMCB 54.71
- MFI N/A
- Support Level
- PMCB $1.00
- MFI N/A
- Resistance Level
- PMCB $1.07
- MFI N/A
- Average True Range (ATR)
- PMCB 0.05
- MFI 0.00
- MACD
- PMCB 0.01
- MFI 0.00
- Stochastic Oscillator
- PMCB 73.33
- MFI 0.00
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About MFI MF INTERNATIONAL LIMITED
mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via the internet or a platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.